Celldex Therapeutics, Inc.Celldex Therapeutics, Inc.Celldex Therapeutics, Inc.

Celldex Therapeutics, Inc.

No trades
See on Supercharts

Price target

67.100.000.00%
The 10 analysts offering 1 year price forecasts for CLDX have a max estimate of — and a min estimate of —.

Analyst rating

Based on 12 analysts giving stock ratings to CLDX in the past 3 months.

EPS

Reported
Estimate
Reported
Estimate
Surprise

Revenue

Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


CLDX EPS for the last quarter is −0.64 USD despite the estimation of −0.67 USD. In the next quarter EPS is expected to reach −0.73 USD. Track more of Celldex Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Celldex Therapeutics, Inc. revenue is expected to reach ‪1.02 M‬ USD. Check out Celldex Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, CLDX price target is 67.10 USD with a max estimate of 90.00 USD and a min estimate of 42.00 USD. Check if this forecast comes true in a year, meanwhile watch Celldex Therapeutics, Inc. stock price chart and keep track of the current situation with CLDX news and stock market news.
We've gathered opinions of 12 analysts rating CLDX stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.